Advertisement
Advertisement

TAK

TAK logo

Takeda Pharmaceutical Company Limited - ADR

17.18
USD
Sponsored
+0.49
+2.91%
Jan 29, 16:00 UTC -5
Closed
exchange

After-Market

17.02

-0.16
-0.94%

TAK Earnings Reports

Positive Surprise Ratio

TAK beat 26 of 38 last estimates.

68%

Next Report

Date of Next Report
May 13, 2026
Estimate for Q4 26 (Revenue/ EPS)
$1.10T
/
-$20.71
Implied change from Q3 26 (Revenue/ EPS)
--
/
--
Implied change from Q4 25 (Revenue/ EPS)
+4.62%
/
-68.30%

Takeda Pharmaceutical Company Limited - ADR earnings per share and revenue

On Jan 28, 2026, TAK reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of 46.75 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 1.20 trillion, with a --% difference.
Looking ahead to Q4 26, 5 analysts forecast an EPS of -20.71 USD, with revenue projected to reach 1.10 trillion USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2026, Takeda Pharmaceutical Company Limited - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for May 13, 2026.
Based on 5 analysts, Takeda Pharmaceutical Company Limited - ADR is expected to report EPS of -$20.71 and revenue of $1.10T for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement